Codify — Article

Reauthorizes Special Diabetes Program for Indians at $160M/year for 2026–2030

Amends the Public Health Service Act to add a statutory funding line of $160 million annually for FY2026–2030 for the Special Diabetes Program for Indians; relevant to tribal health providers and federal appropriators.

The Brief

H.R. 5488 amends section 330C(c)(2) of the Public Health Service Act to add a new subparagraph authorizing $160,000,000 for each of fiscal years 2026 through 2030 for the Special Diabetes Program for Indians, with those amounts to remain available until expended. The bill also performs two small punctuation edits in the existing subparagraph sequence to insert the new funding line.

This is a straight reauthorization/extension focused on funding continuity for the program named in the statute. For tribal health programs and federal budget officers, the bill clarifies a multi‑year statutory funding level but does not change eligibility, program structure, allocation rules, or reporting requirements within the statute itself — leaving implementation detail to the administering agency and appropriators.

At a Glance

What It Does

The bill amends 42 U.S.C. 254c–3(c)(2) by adding subparagraph (H), which specifies $160,000,000 for each fiscal year 2026–2030 and states those funds shall remain available until expended. It also adjusts punctuation in the existing subparagraphs to accommodate the insertion.

Who It Affects

Primary stakeholders are tribal health programs and clinics that receive Special Diabetes Program for Indians (SDPI) funds, the federal agency that administers SDPI, congressional appropriators and budget offices, and the patients served by those programs. Administrative staff at recipient organizations will need to plan for multi‑year funding availability.

Why It Matters

Statutorily authorizing five years of funding provides nominal multi‑year certainty and simplifies planning at the program level if Congress appropriates the amounts. But the authorization is a fixed nominal amount with no inflation adjustment and does not itself appropriate funds or change allocation or oversight mechanisms.

More articles like this one.

A weekly email with all the latest developments on this topic.

Unsubscribe anytime.

What This Bill Actually Does

H.R. 5488 makes a surgical change to the Public Health Service Act: it inserts a new subparagraph (H) into the list of authorized funding amounts for the Special Diabetes Program for Indians. That new line specifies $160,000,000 for each fiscal year from 2026 through 2030 and adds the phrase that these funds shall "remain available until expended." To place the insertion cleanly, the bill also tweaks the punctuation at the ends of the preceding subparagraphs.

Legally, the amendment places a five‑year, line‑item dollar amount in statute. Practically, this creates a statutory authorization for those nominal amounts across five fiscal years; it does not, by itself, obligate money to be spent — Congress still must appropriate funds in annual or supplemental appropriations acts.

The "remain available until expended" language means once appropriated, amounts can be carried forward across fiscal years until spent, which supports longer‑term projects and avoids fiscal year timing pressures.The bill does not modify who qualifies for SDPI funds, how the funds are distributed among tribes or programs, or reporting and oversight requirements inside the statute. Those operational details remain governed by existing statute, agency regulations, grant terms, and appropriations language.

Because the authorization is a fixed nominal figure, recipients and planners should treat it as a baseline; absent appropriations or administrative changes, the value of that baseline will erode with inflation.For federal budget offices and appropriators, the text is simple to score and implement: it identifies a specific annual statutory figure for five years. For program administrators and tribal recipients, the change matters only to the extent Congress follows through with appropriations and the administering agency applies the funds according to existing program rules.

The Five Things You Need to Know

1

The bill amends 42 U.S.C. 254c–3(c)(2) by adding a new subparagraph designated (H).

2

It specifies $160,000,000 authorized for each fiscal year 2026, 2027, 2028, 2029, and 2030.

3

The inserted language states the authorized amounts shall "remain available until expended," allowing multi‑year carryover once appropriated.

4

The text performs two punctuation edits to subparagraphs (F) and (G) to integrate the new (H) cleanly into the statutory list.

5

The amendment only sets a statutory funding amount; it does not change eligibility, allocation formulas, program structure, or reporting requirements in the existing statute.

Section-by-Section Breakdown

Every bill we cover gets an analysis of its key sections. Expand all ↓

Section 1

Short title

Designates the act as the "Special Diabetes Program for Indians Reauthorization Act of 2025." This is purely nominal but useful for citation and for tracking the purpose of the amendment in statutory compilations.

Section 2 (amendment to 42 U.S.C. 254c–3(c)(2))

Inserts a new statutory funding line for SDPI

Subsection (c)(2) is modified to add subparagraph (H), which specifies $160,000,000 for each fiscal year 2026–2030. The insertion places a clear, line‑item dollar figure into the statute, which functions as an authorization of appropriations for those fiscal years. The specific dollar figure and listed years are the core substantive change the statute will record.

Section 2 (technical changes)

Punctuation and structural edits to accommodate the new item

The bill makes two small textual edits—changing end punctuation in existing subparagraphs (F) and (G)—so that the statutory list reads correctly with the new (H). These are mechanical but required to preserve statutory grammar and ensure the new funding line is legally integrated.

At scale

This bill is one of many.

Codify tracks hundreds of bills on Healthcare across all five countries.

Explore Healthcare in Codify Search →

Who Benefits and Who Bears the Cost

Every bill creates winners and losers. Here's who stands to gain and who bears the cost.

Who Benefits

  • Tribal health programs and clinics that receive SDPI grants — the statute creates a five‑year funding authorization that can support multi‑year diabetes prevention and treatment initiatives if Congress appropriates the funds.
  • American Indian and Alaska Native (AI/AN) patients with diabetes — continued statutory funding increases the likelihood of sustained services, education, and community programs tied to SDPI resources.
  • Program planners and grantees — the statutory multi‑year figure, combined with "remain available until expended," allows for longer‑range budgeting and project design assuming appropriations follow the authorization.
  • Community-based providers and health workers funded by SDPI grants — a clearer funding horizon supports staffing and program continuity decisions at the local level.

Who Bears the Cost

  • Federal appropriators and the Treasury — if Congress funds the authorized amounts, those appropriations will affect discretionary outlays and budget allocations.
  • The federal agency that administers SDPI — administering multi‑year carryover and ensuring compliance may increase program management responsibilities without new statutory guidance on allocation or oversight.
  • Tribal grantees and clinics — while they benefit from authorization, fixed nominal funding may not keep pace with inflation or rising service demands, effectively shifting the burden of shortfalls onto local budgets.
  • Congressional budget offices and scorekeepers — the authorization creates a multi‑year baseline that must be incorporated into budget projections and fiscal planning.

Key Issues

The Core Tension

The central tension is between stability and sufficiency: the bill offers nominal multi‑year statutory stability that aids planning, but by fixing a dollar amount without allocation rules, inflation adjustments, or new oversight hooks, it risks leaving program funding insufficient or unevenly distributed while transferring critical implementation choices to appropriators and administrators.

The bill is narrowly focused: it adds a single five‑year funding line to statute and changes two punctuation marks. That economy is efficient but also shifts many consequential decisions away from statutory text.

The amendment does not specify how the $160 million per year would be allocated among tribes or programs, whether there are new performance or reporting requirements, or whether funds should be adjusted for inflation. Those omissions leave allocation, oversight, and the real purchasing power of the authorization to appropriators and the administering agency.

The "remain available until expended" provision supports program continuity by allowing carryover, but it also complicates budget scoring and oversight: multi‑year availability can blur fiscal year accountability and make it harder to link appropriations to annual performance results. Fixed nominal amounts over five years provide predictability in name but can amount to declining real support.

Finally, the mechanical punctuation edits show this is an additive, non‑restructuring reauthorization; stakeholders seeking substantive program reform will not find it here, which may create pressure for separate legislative or administrative actions to address allocation, equity, or performance measurement.

Try it yourself.

Ask a question in plain English, or pick a topic below. Results in seconds.